Jianhua He
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jianhua He has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Shan Lu
Research Center for Pharmaceutical Preparations, School of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065, China
6 shared publications Yujie Guo
5 shared publicationsCan Yang
School of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065, PR China; Research Center for Pharmaceutical Preparations, Hubei University of Chinese Medicine, Wuhan 430065, PR China
4 shared publicationsLiqing Mo
4 shared publicationsYi Hong
4 shared publicationsYingxuan Dai
4 shared publications
Latest Publications
- 17 July 2026
- Published by Elsevier in Materials Today Chemistry
- Vol. 56
Microfluidic formulation of lipid nanoparticles for biomolecule drug delivery
- 17 July 2026
- Published by Elsevier in Materials Today Chemistry
- Vol. 56
Microfluidic formulation of lipid nanoparticles for biomolecule drug delivery
- Open Access
- 26 February 2026
- Published by Elsevier in SSRN Electronic Journal
Harnessing a Hydrophobic Dietary Flavonoid to Overcome Gelation in Co-amorphous System: A Dual-Flavonoid Strategy for Realizing Isoliquiritigenin Solubilization
The poor solubility of dietary flavonoids, such as isoliquiritigenin (ISL), severely restricts their bioavailability. Co-amorphous (CM) technology is a promising strategy to enhance solubility, but its efficacy is often compromised by gelation during dissolution. To overcome this limitation, we innovatively constructed a ternary CM system by incorporating a hydrophobic dietary flavonoid, taxifolin (TAX), into a binary ISL-oxymatrine system. This novel strategy successfully eliminated gelation, resulting in a remarkable enhancement in the solubility and dissolution behaviors of ISL. A combination of solid-state characterization and molecular dynamics simulations revealed that strong intermolecular interactions and the introduction of hydrophobic substances within the ternary system were probably responsible for disrupting the gel network at the molecular level. This study not only provides an effective formulation for ISL but also introduces a novel, clean-label "within-class" strategy to overcome a fundamental limitation in CM technology for delivering poorly soluble bioactives.
- 26 February 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessHarnessing a Hydrophobic Dietary Flavonoid to Overcome Gelation in Co-amorphous System: A Dual-Flavonoid Strategy for Realizing Isoliquiritigenin Solubilization
The poor solubility of dietary flavonoids, such as isoliquiritigenin (ISL), severely restricts their bioavailability. Co-amorphous (CM) technology is a promising strategy to enhance solubility, but its efficacy is often compromised by gelation during dissolution. To overcome this limitation, we innovatively constructed a ternary CM system by incorporating a hydrophobic dietary flavonoid, taxifolin (TAX), into a binary ISL-oxymatrine system. This novel strategy successfully eliminated gelation, resulting in a remarkable enhancement in the solubility and dissolution behaviors of ISL. A combination of solid-state characterization and molecular dynamics simulations revealed that strong intermolecular interactions and the introduction of hydrophobic substances within the ternary system were probably responsible for disrupting the gel network at the molecular level. This study not only provides an effective formulation for ISL but also introduces a novel, clean-label "within-class" strategy to overcome a fundamental limitation in CM technology for delivering poorly soluble bioactives.
- 18 October 2025
- Published by Elsevier in Chinese Chemical Letters
- Vol. 37 (9)
Drug delivery systems for the treatment of venous thrombosis
- 18 October 2025
- Published by Elsevier in Chinese Chemical Letters
- Vol. 37 (9)
Drug delivery systems for the treatment of venous thrombosis
- 28 February 2025
- Published by Elsevier in Journal of Controlled Release
- Vol. 381, 113543
Combination therapy and drug co-delivery systems for atherosclerosis
- 28 February 2025
- Published by Elsevier in Journal of Controlled Release
- Vol. 381, 113543
Combination therapy and drug co-delivery systems for atherosclerosis
- 25 December 2024
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 670, 125133
Novel therapeutic deep eutectic solvents based on mirtazapine and medium-chain fatty acids for enhancing the transdermal delivery of mirtazapine
- 25 December 2024
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 670, 125133
Novel therapeutic deep eutectic solvents based on mirtazapine and medium-chain fatty acids for enhancing the transdermal delivery of mirtazapine
- 8 December 2024
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 287, 138533
Novel drug delivery systems for hirudin-based product development and clinical applications
- 8 December 2024
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 287, 138533
Novel drug delivery systems for hirudin-based product development and clinical applications
- 17 August 2024
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 664, 124592
Study on co-amorphous emerging solubilization behavior after gelation during dissolution: The importance of complexation and anti-crystallization
- 17 August 2024
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 664, 124592
Study on co-amorphous emerging solubilization behavior after gelation during dissolution: The importance of complexation and anti-crystallization
- 5 January 2024
- Published by Elsevier in Journal of Controlled Release
- Vol. 366, 261-281
Navigating the landscape: Prospects and hurdles in targeting vascular smooth muscle cells for atherosclerosis diagnosis and therapy
- 5 January 2024
- Published by Elsevier in Journal of Controlled Release
- Vol. 366, 261-281
Navigating the landscape: Prospects and hurdles in targeting vascular smooth muscle cells for atherosclerosis diagnosis and therapy
- Top Cited Papers
- 7 August 2023
- Published by Elsevier in Food Chemistry
- Vol. 430, 137115
Opportunities and challenges in enhancing the bioavailability and bioactivity of dietary flavonoids: A novel delivery system perspective
- 7 August 2023
- Published by Elsevier in Food Chemistry
- Vol. 430, 137115
Top Cited PapersOpportunities and challenges in enhancing the bioavailability and bioactivity of dietary flavonoids: A novel delivery system perspective